Skip to main content
Premium Trial:

Request an Annual Quote

Q Bio Raises $40M in Series B Financing Round

NEW YORK — Q Bio said on Thursday that it has raised $40 million in Series B funding that it will use to further develop its preventative health technology.

The round was led by venture capital firm Andreessen Horowitz and included Khosla Ventures, Founders Fund, Beast Ventures, Thirty5 Ventures, Sea Lane Ventures, and SciFi VC. In conjunction with the financing, Andreessen Horowitz's Vijay Pande and Khosla Venture's Vinod Khosla will join Q Bio's board.

Including the Series B funding, Q Bio said it has raised $58 million to date.

Founded in 2015, Q Bio is developing a platform that is designed to provide an overview of an individual's health based on their vital signs, a whole-body MRI, blood and urine analyses, and sequenced genetic data. Readouts are available within 75 minutes and can be accessed online by a patient's healthcare provider.

Q Bio said that it opened its first facility in Redwood City, California in late 2019 and that additional locations are planned for later this year.

"By measuring everything from blood to imaging and more in a longitudinal way, patients can have personalized baselines and physicians the data and power to understand, interpret, and utilize this data to personalize care," Pande said in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.